Drugs · Entity Annotation Prototype (beta)

3articles mentioning drugs

10drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: TZDs ×

TZDs

This drug is selected. Its supporting articles are shown below.

TZDs3

Articles mentioning TZDs

3 articles · page 1 of 1

Metabolic factors moderate the association between hepatic fibrosis and atherosclerotic cardiovascular risk in type 2 diabetes

bmjdrc · full text · 2025-11-04 · 6 matching annotations

94.9%

statin TZDs metformin SGLT2i GLP-1RAs meglitinides OADs

…ssociation. One potential explanation is the high prevalence of statin use among patients, which may have attenuated the variability i…

Comparative risk of the neurodegenerative outcomes between sodium-glucose co-transporter 2 (SGLT2) inhibitors and thiazolidinediones in type 2 diabetes: a multicentre cohort study using the Korean healthcare database (2014–2025)

bmjopen · abstract · 2026-02-22 · 3 matching annotations

88.8%

SGLT2 inhibitors TZDs thiazolidinediones Type 2 diabetes mellitus AD type 2 diabetes dementia Alzheimer’s disease

…own to be consistent across multiple hospital sites.Conclusions SGLT2 inhibitors are associated with a reduced risk of dementia and AD compared …

Declining incidence and severity of hypoglycaemia in prehospital care

emermed · abstract · 2026-01-21 · 1 matching annotations

78.8%

dipeptidyl peptidase-4 inhibitors glucagon-like peptide-1 (GLP-1) agonists sodium-glucose co-transporter-2 (SGLT-2) inhibitors thiazolidinediones TZDs hypoglycaemia diabetes treatment diabetes low blood sugar (BS)

… agonists, sodium-glucose co-transporter-2 (SGLT-2) inhibitors, dipeptidyl peptidase-4 inhibitors and thiazolidinediones (TZDs) have minimal risk of hypoglycaemi…